AS, M., PW, E., MM, H., MH, N., SM, W., WW, N., . . . WW, A. (2022). First Detection of Mycobacterium tuberculosis Clinical Isolates Harboring I491F Borderline Resistance rpoB Mutation in Myanmar. Antimicrobial agents and chemotherapy, 66(12), e0092522. https://doi.org/10.1128/aac.00925-22
Chicago Style (17th ed.) CitationAS, Mon, Ei PW, Htwe MM, Nyunt MH, Win SM, Nyunt WW, Myint Z, and Aung WW. "First Detection of Mycobacterium Tuberculosis Clinical Isolates Harboring I491F Borderline Resistance RpoB Mutation in Myanmar." Antimicrobial Agents and Chemotherapy 66, no. 12 (2022): e0092522. https://doi.org/10.1128/aac.00925-22.
MLA (9th ed.) CitationAS, Mon, et al. "First Detection of Mycobacterium Tuberculosis Clinical Isolates Harboring I491F Borderline Resistance RpoB Mutation in Myanmar." Antimicrobial Agents and Chemotherapy, vol. 66, no. 12, 2022, p. e0092522, https://doi.org/10.1128/aac.00925-22.